Dong-Gun Kim

Elevar Therapeutics

Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Our experience is rooted in oncology, and we apply the same rigor and diligence that comes with this knowledge to identifying and developing promising medicines for complex yet under-treated health conditions across a range of therapeutic areas. We develop and assess therapeutics based upon their ability to make a meaningful impact for patients and their treatment experiences. We invest in proven and promising therapeutics at various stages of development and advance them through clinical and regulatory processes with the goal of commercializing improved treatment options for patients and the healthcare providers who treat them. Elevating Outcomes: We take a relentless and inventive approach towards developing and advancing next generation, best-in-class therapies that have the potential to set new standards of care and improve treatment experiences. Evolving Therapeutic Potential: We identify areas where we can develop, build upon or evolve medicines that offer patients improved clinical outcomes. Engaging with Purpose: We are committed to engaging with the highest ethical standards, driven by a passion to address the underserved needs of patients, caregivers and healthcare providers.